Fighting prostate cancer with groundbreaking new technique
MEI Pharma, Inc a pharmaceutical company focused on leveraging its extensive development and oncology expertise to identify and advance new therapies for cancer.
Endometriosis drug approved by the FDA to reduce pain
The Food and Drug Administration announce the approval of the commercial version of the drug elagolix for the treatment of endometriosis pain.
Novartis’s Cultural Revolution Will Be AI-Enabled and Desk-Free
MEI Pharma, Inc a pharmaceutical company focused on leveraging its extensive development and oncology expertise to identify and advance new therapies for cancer.
IIT researchers develop promising TB diagnostics solution
Ravi Elangovan’s decision to leave a cushy research job in Florence and join IIT-Delhi’s faculty in 2010 was driven mostly by personal reasons.
Johnson and Johnson to offer first TB drug in 40 years for $900
US drug maker Johnson and Johnson will offer its new tuberculosis (TB) drug, Bedaquiline, at $900 (Rs 70,000) once its conditional access programme with the government of India ends in 2019, the company said in an interview to ET.